Overcoming P-Glycoprotein-Mediated Doxorubicin Resistance
Intracellular concentration of doxorubicin in target cancer cells is a major determinant of therapeutic success of doxorubicin-based regimens. As known, doxorubicin is a substrate of P-glycoprotein (P-gp), the drug efflux transporter in the ABC superfamily. High expression level of P-gp in cancer ce...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74811 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Overcoming P-Glycoprotein-Mediated Doxorubicin Resistance
- Computational Studies of Drug Repurposing Targeting P-Glycoprotein-Mediated Multidrug Resistance Phenotypes in Priority Infectious Agents
- Computational Studies of Drug Repurposing Targeting P-Glycoprotein-Mediated Multidrug-Resistance Phenotypes in Agents of Neglected Tropical Diseases
- P-Glycoprotein Efflux Transporters and Its Resistance Its Inhibitors and Therapeutic Aspects
- Overview on the Side Effects of Doxorubicin
- Cardioprotection Using Doxorubicin: The Role of Dexrazoxane
- HIV-1 Glycoprotein Immunogenicity